Researchers at the Loke Centre for Trophoblast Research at the University of Cambridge have developed a groundbreaking real-time imaging technique that reveals significant genetic abnormalities in pre-implantation embryos. This study, published in Nature Biotechnology, highlights the potential for high-resolution light-sheet microscopy to observe embryo development without causing damage, a first in the field.
Through this innovative approach, the researchers discovered that approximately 10% of the embryos exhibited chromosomal abnormalities, primarily in cells destined to become the placenta. These findings challenge the current practices of preimplantation genetic testing, which typically focuses on biopsying these very cells. Senior author Kathy Niakan emphasized the need for further research to understand the implications of these late-stage genetic anomalies on embryo viability and the timing of embryo transfer.
The implications of this research are profound, suggesting that existing screening methods may not accurately reflect embryo health. As the field of assisted conception evolves, these insights could lead to a reevaluation of clinical practices, ultimately improving success rates for IVF treatments.
Use the database as your supply chain compass →
